Migraine Headaches Study
- February 20, 2019
The purpose of this study is to evaluate the safety and effectiveness of a single dose of an investigational medication in the acute treatment of migraine headaches in adults who’ve had an inadequate response to prior acute treatments.
Duration: Up to 13 weeks
Number of Visits to CKRA: 3
Compensation is available for time and travel.
Note: Qualified participants must be between the ages of 18 and 65 years old, have been diagnosed by a physician as having migraines, and must not suffer from cluster headaches or other chronic headache disorders. Other criteria also apply.